Literature DB >> 33911581

Docetaxel-Aggravated Psoriasis.

Seungkeol Yang1, Bo Ri Kim1, Chong Won Choi1, Sang Woong Youn1.   

Abstract

Entities:  

Year:  2019        PMID： 33911581      PMCID： PMC7992687          DOI： 10.5021/ad.2019.31.2.240

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  5 in total

1.  [Docetaxel-induced psoriasis].

Authors:  D Kerob; C Le Maignan; M-D Vignon-Pennamen; C Lebbe
Journal:  Ann Dermatol Venereol       Date:  2010-11       Impact factor: 0.777

2.  [Docetaxel-induced psoriasis].

Authors:  I Allende; R González-Hermosa; M Lázaro; J L Díaz-Pérez
Journal:  Actas Dermosifiliogr       Date:  2009-09

Review 3.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

4.  A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.

Authors:  Krithika N Kodumudi; Karrune Woan; Danielle L Gilvary; Eva Sahakian; Sheng Wei; Julie Y Djeu
Journal:  Clin Cancer Res       Date:  2010-08-11       Impact factor: 12.531

5.  Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.

Authors:  Ming J Poi; Michael Berger; Maryam Lustberg; Rachel Layman; Charles L Shapiro; Bhuvaneswari Ramaswamy; Ewa Mrozek; Erin Olson; Robert Wesolowski
Journal:  Support Care Cancer       Date:  2013-05-19       Impact factor: 3.603
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.